Approval · Notice of Compliance 30005 · 2023
LETYBO: Notice of Compliance 30005
Issued January 25, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30005
- Date
- January 25, 2023
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph and label updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LETYBO | Not yet assigned | — |
Medicinal ingredients
- LETIBOTULINUMTOXINA 50 UNIT per VIAL
- LETIBOTULINUMTOXINA 100 UNIT per VIAL